WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc.
(NYSE: ALR) announced today that Abbott's acquisition of Alere is
intended to close on October 3, 2017.
The announcement follows receipt of all regulatory clearances
necessary for closing.
Alere intends to request that the New York Stock Exchange cease
trading of Alere's common stock before market open on October 3, 2017.
About Alere
Alere believes that when diagnosing and
monitoring health conditions, Knowing now matters™. Alere delivers
reliable and actionable information by providing rapid diagnostic
tests, enhancing clinical and economic healthcare outcomes
globally. Headquartered in Waltham,
Mass., Alere focuses on rapid diagnostics for
cardiometabolic disease, infectious disease and toxicology.
For more information on Alere, please visit www.alere.com.
Cautionary Statement Regarding Forward-Looking
Statements
This communication contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. A number of important factors could cause
actual results of Alere and its subsidiaries to differ materially
from those indicated by such forward-looking statements, including
the risk that the proposed merger with Abbott may not be completed,
the risk factors detailed in Part I, Item 1A, "Risk Factors," of
our Annual Report on Form 10-K for the fiscal year ended
Dec. 31, 2016 (as filed with the SEC
on June 5, 2017) and other risk
factors identified from time to time in our periodic filings with
the SEC. Readers should carefully review these risk factors, and
should not place undue reliance on our forward-looking statements.
These forward-looking statements are based on information, plans
and estimates at the date of this communication. We undertake no
obligation to update any forward-looking statements to reflect
changes in underlying assumptions or factors, new information,
future events or other changes.
View original
content:http://www.prnewswire.com/news-releases/abbott-acquisition-of-alere-set-to-close-on-october-3-2017-300528261.html
SOURCE Alere Inc.